Based on its VitroGro®
technology, Tissue Therapies is developing more effective treatments
for acute and chronic wound healing applications including chronic skin
ulcers and burns.
Tissue Therapies is also proceeding
with the development of other commercial applications for VitroGro® and
other technologies for the treatment of psoriasis, scar prevention and
treatment and potential treatments for various cancers including those
of the breast, colon and prostate.
|
The management and technical team of Tissue Therapies are highly
qualified and experienced.
 |
Interview with Dr. Steve Mercer CEO & Director of Tissue
Therapies Ltd. |
|
Tissue Therapies current share price
is available on the ASX.
|
 |
|
